Financial Perspectives’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$497 Hold
83
﹤0.01% 676
2025
Q4
$595 Sell
83
-20
-19% -$158 ﹤0.01% 675
2025
Q3
$1.1K Hold
103
﹤0.01% 660
2025
Q2
$997 Hold
103
﹤0.01% 662
2025
Q1
$1.53K Hold
103
﹤0.01% 642
2024
Q4
$1.54K Hold
103
﹤0.01% 644
2024
Q3
$1.97K Hold
103
﹤0.01% 592
2024
Q2
$2.13K Hold
103
﹤0.01% 572
2024
Q1
$1.94K Sell
103
-33
-24% -$566 ﹤0.01% 574
2023
Q4
$1.96K Sell
136
-19
-12% -$258 ﹤0.01% 597
2023
Q3
$2.69K Hold
155
﹤0.01% 571
2023
Q2
$3.22K Buy
155
+1
+0.6% +$22 ﹤0.01% 546
2023
Q1
$3.63K Hold
154
﹤0.01% 538
2022
Q4
$4.31K Hold
154
﹤0.01% 527
2022
Q3
$3.61K Hold
154
﹤0.01% 539
2022
Q2
$5.21K Hold
154
﹤0.01% 513
2022
Q1
$5.39K Hold
154
﹤0.01% 530
2021
Q4
$4.69K Hold
154
﹤0.01% 523
2021
Q3
$5.05K Hold
154
﹤0.01% 516
2021
Q2
$4.66K Buy
+154
New +$5.07K ﹤0.01% 551

Other funds holding OGN

Financial Perspectives's OGN Position: Q1 2026 in Review

Financial Perspectives held its Organon & Co (OGN) position steady in Q1 2026 at 83 shares worth $497. The position accounts for ﹤0.01% of the portfolio, ranked #676.

Financial Perspectives first reported a position in OGN in Q2 2021 and has held it in 20 quarters since. The position peaked at $5.39K in Q1 2022. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • Financial Perspectives held 83 shares of Organon & Co worth $497 as of Q1 2026.
  • Financial Perspectives left its Organon & Co share count unchanged in Q1 2026.
  • Organon & Co made up ﹤0.01% of Financial Perspectives's portfolio in Q1 2026, its #676 holding.
  • Financial Perspectives first reported a position in Organon & Co in Q2 2021 and has held it in 20 quarters since.
  • Financial Perspectives's Organon & Co position peaked at $5.39K in Q1 2022.
  • 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Financial Perspectives's 13F filing for Q1 2026, filed 11 May 2026.